Now showing items 1-1 of 1
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
(Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2019)
Background Lithium is recommended as a first line treatment for bipolar disorders. However, only 30% of patients show an optimal outcome and variability in lithium response and tolerability is poorly ...